Pluri Inc

PLUR

Company Profile

  • Business description

    Pluri Inc is a biotechnology company, that creates cell-based products for commercial use and is pioneering a biotech revolution that promotes wellbeing and sustainability. The company’s technology platform developed a three-dimensional, or 3D, technology platform for cell expansion with an industrial scale in-house Good Manufacturing Practice, or GMP, cell manufacturing facility. It uses its technology in the field of regenerative medicine, food tech and agricultural technology or agtech.

  • Contact

    MATAM Advanced Technology Park
    Building No.5
    Haifa3508409
    ISR

    T: +972 747108600

    E: [email protected]

    https://www.pluri-biotech.com

  • Sector

    Healthcare

    Stock type

    Defensive

  • Industry

    Biotechnology

    Fiscal Year End

    30 June 2025

    Employees

    118

Stocks News & Analysis

stocks

What next for the largest company on the ASX?

After a historic rally in 2024, what lies ahead for this overvalued banking titan?
stocks

Ask the analyst: Are IDP Education's woes temporary?

The global education services provider has gone from stock market darling to one of the ASX's weakest performers. What gives?
stocks

Is it time to buy the Magnificent Seven?

After the recent selloff, the bull market’s most in-demand stocks look much cheaper.

Morningstar Investment Ideas

Markets

Index
Last price
Change
% Change
All Ordinaries7,988.9022.300.28%
CAC 407,938.2150.75-0.64%
DAX 4022,567.14109.27-0.48%
Dow JONES (US)40,813.57537.36-1.30%
FTSE 1008,542.561.590.02%
HKSE23,462.65137.66-0.58%
NASDAQ17,303.01345.44-1.96%
Nikkei 22536,790.0329.06-0.08%
NZX 50 Index12,167.5241.53-0.34%
S&P 5005,521.5277.78-1.39%
S&P/ASX 2007,772.0022.900.30%
SSE Composite Index3,358.7313.20-0.39%

Market Movers